These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3121667)

  • 1. Disk diffusion susceptibility testing and broth microdilution quality control guidelines for BMY-28100, a new orally administered cephalosporin.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Nov; 25(11):2211-3. PubMed ID: 3121667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
    Fuchs PC; Jones RN; Barry AL; Gavan TL
    J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL; Thornsberry C; Gavan TL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-strain regression analysis for determination of interpretive breakpoints for cefoperazone disk diffusion susceptibility testing.
    Kronvall G
    J Clin Microbiol; 1983 Jun; 17(6):975-80. PubMed ID: 6223938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility testing quality control studies with fosfomycin tromethamine.
    Fuchs PC; Barry AL; Brown SD
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):538-40. PubMed ID: 9272392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality control limits for microdilution susceptibility tests with norfloxacin.
    Barry AL; Gavan TL; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
    J Clin Microbiol; 1987 Jan; 25(1):165-6. PubMed ID: 3098779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of BMS284756 MIC and 5-microg disk diffusion quality control studies tested against seven American type culture collection strains.
    Biedenbach DJ; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Dec; 41(4):225-8. PubMed ID: 11777665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL; Jones RN
    J Clin Microbiol; 1990 Mar; 28(3):605-7. PubMed ID: 2182675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Nov; 25(11):2243-6. PubMed ID: 3693552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of an orally administered cephalosporin, LY164846, against potentially pathogenic respiratory and dermal bacterial isolates.
    Lauderdale BL; Yu PK; Washington JA
    Antimicrob Agents Chemother; 1986 Apr; 29(4):560-4. PubMed ID: 3486628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disk agar diffusion susceptibility testing with 30-micrograms ceftazidime disks: confirmation of interpretive breakpoints and quality control guidelines.
    Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1983 Jul; 18(1):211-4. PubMed ID: 6350348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L; Biedenbach DJ; Jones RN
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing.
    Ayers LW; Jones RN; Barry AL; Thornsberry C; Fuchs PC; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1982 Nov; 22(5):859-77. PubMed ID: 6983862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.
    Jones RN; Gavan TL; Barry AL; Thornsberry C; Gibbs DL
    J Clin Microbiol; 1982 May; 15(5):777-86. PubMed ID: 6212596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tentative disk diffusion susceptibility interpretive criteria for BMY-28142, a new cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1986 Mar; 23(3):634-6. PubMed ID: 3754266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretive criteria and quality control for antimicrobial susceptibility tests of levofloxacin.
    Barry A; Fuchs P; Tenover F; Allen S; Hardy D; Jorgensen J; McLaughlin J; Reller L
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):822-6. PubMed ID: 7889952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
    Jones RN; Barry AL
    J Clin Microbiol; 1988 Apr; 26(4):770-3. PubMed ID: 3259247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretive standards and quality control guidelines for cefpiramide disk susceptibility tests.
    Barry AL; Gavan TL; Thornsberry C; Jones RN
    J Clin Microbiol; 1985 Oct; 22(4):688-90. PubMed ID: 4077974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Disk Diffusion and MIC Quality Control Ranges for Nafithromycin (WCK 4873), a New Lactone-Ketolide.
    Hackel MA; Karlowsky JA; Dressel D; Sahm DF
    J Clin Microbiol; 2017 Oct; 55(10):3021-3027. PubMed ID: 28747372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.